• U.S. anti-legalization group urges more access to marijuana research (Reuters)

    by  • May 29, 2015 • Daily Digests • 1 Comment

    Only the University of Mississippi has the federal go-ahead to research the medical value of cannabis. Smart Approaches to Marijuana is trying to change that, though they oppose recreational marijuana legalization, skeptical that a legalization model able to constrain commercial harm will be adopted by states considering legalization. Asserting the value of cannabidiol over THC, the psychoactive component of marijuana, would provide anti-legalization groups with munition against drugs that also contain THC, and pro-recreational policy recommendations in general. 

    By ALEX DOBUZINSKIS | May 28, 2015

    A group opposed to pot legalization is unveiling proposals on Thursday for the U.S. government to ease restrictions on scientific research into marijuana’s potential as medicine, in a first step for an organization of its kind.

    The plan from Smart Approaches to Marijuana, which is co-founded by former U.S. Congressman Patrick Kennedy, comes after three U.S. Senators this year introduced a bill that would require the federal government to recognize pot’s medical value and allow states to set their own medical cannabis policies.

    Read More

    About

    One Response to U.S. anti-legalization group urges more access to marijuana research (Reuters)

    1. Don E.
      November 2, 2015 at 12:35 pm

      It’s great that they are pushing to open up research, but the folks at project Sam are delusional if they think CBD is the only medically beneficial component of cannabis. The research will likely show that many other components, including THC, have medical applications. SAM is unwittingly pushing open the door to it’s own demise.

    Leave a Reply